Viewing Study NCT03421054



Ignite Creation Date: 2024-05-06 @ 11:03 AM
Last Modification Date: 2024-10-26 @ 12:39 PM
Study NCT ID: NCT03421054
Status: COMPLETED
Last Update Posted: 2019-10-01
First Post: 2018-01-29

Brief Title: Pilot Trial to Assess the Feasibility of Implementing Objective Parameters in Patients Affected by Knee Osteoarthritis
Sponsor: River Pharma Srl
Organization: River Pharma Srl

Study Overview

Official Title: Pilot Open Non-controled Trial to Assess the Feasibility of Implementing Objective Parameters as Primary Endpoints in a Clinical Trial With Patients Affected by Knee Osteoarthritis
Status: COMPLETED
Status Verified Date: 2019-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SMILE
Brief Summary: Pilot open non-controlled trial to assess the feasibility of implementing objective parameters as primary endpoints in a clinical trial with patients affected by knee osteoarthritis
Detailed Description: to assess the feasibility of implementing ultrasonography and Range of motion ROM as objective measurements to correlate the improvement of the knee mobility with the pain reduction of the affected knee in the patients assuming nutraceutical containing HA

The secondary objectives of the trial are

to assess the feasibility of implementing Actigraphy as objective measurements to correlate the improvement of the knee mobility with the pain reduction optional
to evaluate the enrollment range in one month

The explorative objectives of the trial are

Preliminary data on efficacy of the tested product

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None